{"id":116303,"date":"2025-05-08T15:28:06","date_gmt":"2025-05-08T14:28:06","guid":{"rendered":"https:\/\/helloproject.es\/vigilancia\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\/"},"modified":"2025-05-08T15:28:06","modified_gmt":"2025-05-08T14:28:06","slug":"inmunoterapia-el-tratamiento-clave-contra-los-melanomas","status":"publish","type":"post","link":"https:\/\/helloproject.es\/vigilancia\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\/","title":{"rendered":"Inmunoterapia, el tratamiento clave contra los melanomas"},"content":{"rendered":"

El melanoma es la forma m\u00e1s agresiva de c\u00e1ncer de piel, y su incidencia sigue en alza en Espa\u00f1a. Seg\u00fan los datos en nuestro pa\u00eds, recogidos por la Red Espa\u00f1ola de Registros de C\u00e1ncer<\/a> (REDECAN), en 2025 se estima que ser\u00e1n diagnosticados 9 400 nuevos casos, con una incidencia en la poblaci\u00f3n de 15 casos por cada 100 000 personas al a\u00f1o. De estos, 5 072 corresponden a mujeres y 4 336 a hombres.<\/p>\n

Se estima que en 2025 se diagnosticar\u00e1n 9 400 nuevos casos de melanoma en Espa\u00f1a<\/p>\n

Esta patolog\u00eda, que ya causa 1 000 muertes al a\u00f1o en Espa\u00f1a, es una de las que se abordan estos d\u00edas en el 52\u00ba Congreso de la Academia Espa\u00f1ola de Dermatolog\u00eda y Venereolog\u00eda<\/a> que se celebra en Valencia entre el 7 y el 10 de mayo.<\/p>\n

Entre los nuevos tratamientos que se comparten destaca el uso de la inmunoterapia, que potencia el sistema inmune del paciente para que pueda identificar y eliminar por s\u00ed solo c\u00e9lulas cancerosas.<\/p>\n

<\/a><\/p>\n

Inmunoterapia para tumores avanzados<\/h2>\n

Onofre Sanmart\u00edn, jefe del servicio de Dermatolog\u00eda de la Fundaci\u00f3n Instituto Valenciano de Oncolog\u00eda (IVO), se\u00f1ala a SINC que la mejor estrategia contra el melanoma sigue siendo su diagn\u00f3stico precoz y el tratamiento quir\u00fargico. Pero en los casos en los que no es posible, la inmunoterapia es la opci\u00f3n m\u00e1s prometedora.<\/p>\n

La inmunoterapia \u2018despierta\u2019 el sistema inmune de los pacientes para que ataque el tumor hasta que ya sea apto para ser tratado quir\u00fargicamente<\/p>\n

\u201cUno de los principales avances en el tratamiento de esta patolog\u00eda en los \u00faltimos a\u00f1os es el uso de la inmunoterapia como neoadyuvancia, es decir, us\u00e1ndola en tumores que est\u00e1n en estado avanzado y no pueden ser extirpados\u201d, dice Sanmart\u00edn.<\/p>\n

As\u00ed, \u2018despiertan\u2019 el sistema inmune de los pacientes para que ataquen el tumor hasta que ya sea apto para ser tratado quir\u00fargicamente. Seg\u00fan el dermat\u00f3logo, tambi\u00e9n se ha avanzado en el uso de esta terapia para evitar que un tumor vuelva a salir despu\u00e9s de su tratamiento.<\/p>\n

<\/a><\/p>\n

La prevenci\u00f3n, la mejor estrategia<\/h2>\n

El especialista tambi\u00e9n subraya que la estrategia m\u00e1s eficaz contra el melanoma es la prevenci\u00f3n. \u201cEs importante evitar las quemaduras solares y la exposici\u00f3n excesiva al sol, especialmente en ni\u00f1os y j\u00f3venes, especialmente durante las horas centrales del d\u00eda\u201d, afirma Sanmart\u00edn.<\/p>\n

Aunque existen factores gen\u00e9ticos, el da\u00f1o que suele llevar al melanoma ocurre por una exposici\u00f3n excesiva al sol<\/p>\n

As\u00ed, explica que aunque existen factores gen\u00e9ticos que predisponen a algunas personas a sufrir este tipo de c\u00e1ncer, mucho del da\u00f1o que lleva a esta dolencia ocurre por una exposici\u00f3n excesiva al sol. Por eso, tambi\u00e9n insiste en el uso de ropa adecuada, gafas de sol, crema fotoprotectora y evitar las cabinas de bronceado.<\/p>\n

Para ayudar a los especialistas a investigar sobre la mejor forma de prevenir y tratar un melanoma, la AEDV cuenta con un Registro Nacional de Melanoma<\/a> que recopila datos cl\u00ednicos sobre esta enfermedad a escala nacional para analizar las caracter\u00edsticas de la dolencia en el pa\u00eds, monitorizar la evoluci\u00f3n de los pacientes y valorar la efectividad y seguridad de los tratamientos. As\u00ed, se pretender caracterizar mejor los factores de riesgo de esta enfermedad, tanto los individuales como los que se relacionan con la atenci\u00f3n sanitaria.<\/p>\n

Adem\u00e1s, desde la AEDV apuntan que la detecci\u00f3n temprana del melanoma es crucial para mejorar la supervivencia y reducir la morbilidad asociada al tratamiento del mismo. Por eso, llaman a la autoexploraci\u00f3n regular de la piel y consultar con un especialista en caso de cualquier lesi\u00f3n sospechosa o que haya cambiado.<\/p>","protected":false},"excerpt":{"rendered":"

El melanoma es la forma m\u00e1s agresiva de c\u00e1ncer de piel, y su incidencia sigue en alza en Espa\u00f1a. Seg\u00fan los datos en nuestro pa\u00eds, recogidos por la Red Espa\u00f1ola de Registros de C\u00e1ncer (REDECAN), en 2025 se estima que ser\u00e1n diagnosticados 9 400 nuevos casos, con una incidencia en la poblaci\u00f3n de 15 casos […]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[5],"tags":[],"class_list":["post-116303","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"\nInmunoterapia, el tratamiento clave contra los melanomas - bip4ex<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/helloproject.es\/vigilancia\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inmunoterapia, el tratamiento clave contra los melanomas\" \/>\n<meta property=\"og:description\" content=\"El melanoma es la forma m\u00e1s agresiva de c\u00e1ncer de piel, y su incidencia sigue en alza en Espa\u00f1a. Seg\u00fan los datos en nuestro pa\u00eds, recogidos por la Red Espa\u00f1ola de Registros de C\u00e1ncer (REDECAN), en 2025 se estima que ser\u00e1n diagnosticados 9 400 nuevos casos, con una incidencia en la poblaci\u00f3n de 15 casos […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/helloproject.es\/vigilancia\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\/\" \/>\n<meta property=\"og:site_name\" content=\"bip4ex\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-08T14:28:06+00:00\" \/>\n<meta name=\"author\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\\\/\"},\"author\":{\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\"},\"headline\":\"Inmunoterapia, el tratamiento clave contra los melanomas\",\"datePublished\":\"2025-05-08T14:28:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\\\/\"},\"wordCount\":640,\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\\\/\",\"name\":\"Inmunoterapia, el tratamiento clave contra los melanomas - bip4ex\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\"},\"datePublished\":\"2025-05-08T14:28:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inmunoterapia, el tratamiento clave contra los melanomas\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"name\":\"bip4ex\",\"description\":\"Vigilancia Tecnol\u00f3gica\",\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\",\"name\":\"Helloproject.es\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"contentUrl\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"width\":322,\"height\":365,\"caption\":\"Helloproject.es\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\",\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/author\\\/luismi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Inmunoterapia, el tratamiento clave contra los melanomas - bip4ex","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/helloproject.es\/vigilancia\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\/","og_locale":"es_ES","og_type":"article","og_title":"Inmunoterapia, el tratamiento clave contra los melanomas","og_description":"El melanoma es la forma m\u00e1s agresiva de c\u00e1ncer de piel, y su incidencia sigue en alza en Espa\u00f1a. Seg\u00fan los datos en nuestro pa\u00eds, recogidos por la Red Espa\u00f1ola de Registros de C\u00e1ncer (REDECAN), en 2025 se estima que ser\u00e1n diagnosticados 9 400 nuevos casos, con una incidencia en la poblaci\u00f3n de 15 casos […]","og_url":"https:\/\/helloproject.es\/vigilancia\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\/","og_site_name":"bip4ex","article_published_time":"2025-05-08T14:28:06+00:00","author":"Luis Miguel Mej\u00edas Ramos","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Luis Miguel Mej\u00edas Ramos","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/helloproject.es\/vigilancia\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\/#article","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\/"},"author":{"name":"Luis Miguel Mej\u00edas Ramos","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca"},"headline":"Inmunoterapia, el tratamiento clave contra los melanomas","datePublished":"2025-05-08T14:28:06+00:00","mainEntityOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\/"},"wordCount":640,"publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/helloproject.es\/vigilancia\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\/","url":"https:\/\/helloproject.es\/vigilancia\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\/","name":"Inmunoterapia, el tratamiento clave contra los melanomas - bip4ex","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/#website"},"datePublished":"2025-05-08T14:28:06+00:00","breadcrumb":{"@id":"https:\/\/helloproject.es\/vigilancia\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/helloproject.es\/vigilancia\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/helloproject.es\/vigilancia\/inmunoterapia-el-tratamiento-clave-contra-los-melanomas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/helloproject.es\/vigilancia\/"},{"@type":"ListItem","position":2,"name":"Inmunoterapia, el tratamiento clave contra los melanomas"}]},{"@type":"WebSite","@id":"https:\/\/helloproject.es\/vigilancia\/#website","url":"https:\/\/helloproject.es\/vigilancia\/","name":"bip4ex","description":"Vigilancia Tecnol\u00f3gica","publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/helloproject.es\/vigilancia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/helloproject.es\/vigilancia\/#organization","name":"Helloproject.es","url":"https:\/\/helloproject.es\/vigilancia\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/","url":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","contentUrl":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","width":322,"height":365,"caption":"Helloproject.es"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca","name":"Luis Miguel Mej\u00edas Ramos","url":"https:\/\/helloproject.es\/vigilancia\/author\/luismi\/"}]}},"_links":{"self":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/116303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/comments?post=116303"}],"version-history":[{"count":0,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/116303\/revisions"}],"wp:attachment":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/media?parent=116303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/categories?post=116303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/tags?post=116303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}